Product Liability And The Economics Of Pharmaceuticals And Medical Devices
Download Product Liability And The Economics Of Pharmaceuticals And Medical Devices full books in PDF, epub, and Kindle. Read online free Product Liability And The Economics Of Pharmaceuticals And Medical Devices ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Product Liability and the Economics of Pharmaceuticals and Medical Devices
Author | : Steven Garber |
Publsiher | : RAND Corporation |
Total Pages | : 272 |
Release | : 1993 |
Genre | : Business & Economics |
ISBN | : STANFORD:36105061069972 |
Download Product Liability and the Economics of Pharmaceuticals and Medical Devices Book in PDF, Epub and Kindle
This study examined the economic effects of product liability on firms producing drugs and medical devices. The study found that the liability system enhances the economic contributions of the industries in some ways.
Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals
Author | : Steven Garber |
Publsiher | : Rand Corporation |
Total Pages | : 117 |
Release | : 2013 |
Genre | : Business & Economics |
ISBN | : 9780833079916 |
Download Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals Book in PDF, Epub and Kindle
Liability effects on the economic performance of the pharmaceutical industry play a prominent role in the debate about the economic effects of product liability in the United States. The author analyzes incentive effects on company decisions, implications for economic outcomes such as drug safety and effectiveness, and suggests how public policy changes could mitigate liability-based sources of inefficient decisions of pharmaceutical companies.
Innovation and the Pharmaceutical Industry
Author | : H. Tristram Engelhardt |
Publsiher | : M & M Scrivener Press |
Total Pages | : 253 |
Release | : 2014-05-14 |
Genre | : Business & Economics |
ISBN | : 9780980209471 |
Download Innovation and the Pharmaceutical Industry Book in PDF, Epub and Kindle
Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit examines the central role of profit in the development of pharmaceuticals, medical devices, and health care generally. Recent efforts to understand this role have often underestimated and even dismissed its importance, arguing for its replacement by other means and mechanisms. However, as the essays in this volume attest, it would be impossible to account adequately for the range of pharmaceuticals and medical devices that have become part of everyday medicine without recognizing that the depth and scope of innovations are tied not simply to altruism, a concern for the common good, or the pursuit of knowledge for its own sake, but crucially to the pursuit of private good and of individual profit. Balancing a concern for theory and practice, the analyses and evaluations provided in these essays touch directly on many of the most heated and important debates in pharmaceutical ethics, such as profit margins, corporate social responsibility, drug advertising, litigation, patents, and parallel trade. Reflecting critically on the problems and prospects of medical innovation, they invite a rethinking of the foundations of the bioethics and business ethics of the pharmaceutical and medical device industries by focusing on the long-term impact of policy decisions for human health and well-being.
Pharmaceutical and Medical Device Safety
Author | : Sonia Macleod,Sweta Chakraborty |
Publsiher | : Unknown |
Total Pages | : 298 |
Release | : 2019 |
Genre | : Electronic Book |
ISBN | : 1509916768 |
Download Pharmaceutical and Medical Device Safety Book in PDF, Epub and Kindle
"This book examines how regulatory and liability mechanisms have impacted upon product safety decisions in the pharmaceutical and medical devices sectors in Europe, the USA and beyond since the 1950s. Thirty-five case studies illustrate the interplay between the regulatory regimes and litigation. Observations from medical practice have been the overwhelming means of identifying post-marketing safety issues. Drug and device safety decisions have increasingly been taken by public regulators and companies within the framework of the comprehensive regulatory structure that has developed since the 1960s. In general, product liability cases have not identified or defined safety issues, and function merely as compensation mechanisms. This is unsurprising as the thresholds for these two systems differ considerably; regulatory action can be triggered by the possibility that a product might be harmful, whereas establishing liability in litigation requires proving that the product was actually harmful. As litigation normally post-dates regulatory implementation, the 'private enforcement' of public law has generally not occurred in these sectors. This has profound implications for the design of sectoral regulatory and liability regimes, including associated features such as extended liability law, class actions and contingency fees. This book forms a major contribution to the academic debate on the comparative utility of regulatory and liability systems, on public versus private enforcement, and on mechanisms of behaviour control."--Bloomsbury Publishing.
The Changing Economics of Medical Technology
Author | : Institute of Medicine,Committee on Technological Innovation in Medicine |
Publsiher | : National Academies Press |
Total Pages | : 225 |
Release | : 1991-02-01 |
Genre | : Medical |
ISBN | : 9780309044912 |
Download The Changing Economics of Medical Technology Book in PDF, Epub and Kindle
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
Product Liability Standards
Author | : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Commerce, Consumer Protection, and Competitiveness |
Publsiher | : Unknown |
Total Pages | : 510 |
Release | : 1994 |
Genre | : Business & Economics |
ISBN | : UCR:31210011562327 |
Download Product Liability Standards Book in PDF, Epub and Kindle
The Product Liability Fairness Act
Author | : United States. Congress. Senate. Committee on the Judiciary |
Publsiher | : Unknown |
Total Pages | : 176 |
Release | : 1995 |
Genre | : Law |
ISBN | : PSU:000024360302 |
Download The Product Liability Fairness Act Book in PDF, Epub and Kindle
Distributed to some depository libraries in microfiche.
Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals
Author | : Steven Garber |
Publsiher | : Rand Corporation |
Total Pages | : 217 |
Release | : 2013-02-15 |
Genre | : Law |
ISBN | : 9780833079893 |
Download Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals Book in PDF, Epub and Kindle
Liability effects on the economic performance of the pharmaceutical industry play a prominent role in the debate about the economic effects of product liability in the United States. The author analyzes incentive effects on company decisions, implications for economic outcomes such as drug safety and effectiveness, and suggests how public policy changes could mitigate liability-based sources of inefficient decisions of pharmaceutical companies.